Omipalisib

CAS No. 1086062-66-9

Omipalisib ( GSK-212;GSK-2126458;GSK2126458 )

Catalog No. M10336 CAS No. 1086062-66-9

A highly potent dual inhibitor PI3K/mTOR inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 51 In Stock
10MG 87 In Stock
25MG 160 In Stock
50MG 264 In Stock
100MG 404 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Omipalisib
  • Note
    Research use only, not for human use.
  • Brief Description
    A highly potent dual inhibitor PI3K/mTOR inhibitor.
  • Description
    A highly potent dual inhibitor PI3K/mTOR inhibitor with app Ki of 19/130/24/60/180/300 nM for p110α/p110β/p110γ/p110δ/mTORC1/mTORC2 respectively; shows equivalent activity for p110α mutants E542K/E545K/H1047R with Ki of 8/8/9 nM; inhibits pAKT-S473 in T47D cells (IC50=0.41 nM), also inhibits phosphorylation of AKTT308 and p70S6K; active in vivo and orally bioavailable.Solid Tumors Phase 1 Clinical
  • Synonyms
    GSK-212;GSK-2126458;GSK2126458
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    mTORC1;p110α;p110β;p110γ;p110δ
  • Research Area
    Cancer
  • Indication
    Solid Tumors

Chemical Information

  • CAS Number
    1086062-66-9
  • Formula Weight
    505.50
  • Molecular Formula
    C25H17F2N5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=S(C1=CC=C(F)C=C1F)(NC2=CC(C3=CC=C4N=CC=C(C5=CC=NN=C5)C4=C3)=CN=C2OC)=O
  • Chemical Name
    Benzenesulfonamide, 2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Knight SD, et al. ACS Med Chem Lett. 2010 Jan 19;1(1):39-43.
2. Khalili JS, et al. Clin Cancer Res. 2012 Aug 15;18(16):4345-55.
3. Munster P, et al. Clin Cancer Res. 2016 Apr 15;22(8):1932-9.
molnova catalog
related products
  • Trihexyphenidyl hydr...

    Trihexyphenidyl hydrochloride is an antiparkinsonian agent of the antimuscarinic class.

  • LTURM34

    LTURM34 is an inhibitor of DNA-PK with IC50 of 34 nM. LTURM34 displays effective antiproliferative activity in a wide range of tumor cell lines.

  • GDC-0326

    A potent, selective, orally available PI3Kα inhibitor with Ki of 0.2 nM; displays 133, 20 and 33-fold selectivity over PI3Kβ, PI3Kδ and PI3Kγ, respectively.